NO964451L - Röntgenkontrastblandinger inneholdende farmasöytisk akseptable leirer - Google Patents

Röntgenkontrastblandinger inneholdende farmasöytisk akseptable leirer

Info

Publication number
NO964451L
NO964451L NO964451A NO964451A NO964451L NO 964451 L NO964451 L NO 964451L NO 964451 A NO964451 A NO 964451A NO 964451 A NO964451 A NO 964451A NO 964451 L NO964451 L NO 964451L
Authority
NO
Norway
Prior art keywords
pharmaceutically acceptable
ray contrast
compositions containing
containing pharmaceutically
contrast compositions
Prior art date
Application number
NO964451A
Other languages
English (en)
Other versions
NO964451D0 (no
Inventor
Stephen B Ruddy
Gregory L Mcintire
Mary E Roberts
John L Toner
Edward R Bacon
Tom Caufield
Eugene R Cooper
Brent D Douty
Carl R Illig
Kimberly Estep
Original Assignee
Nycomed Imaging As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/230,580 external-priority patent/US5476646A/en
Priority claimed from US08/236,287 external-priority patent/US5424056A/en
Priority claimed from US08/237,502 external-priority patent/US5492687A/en
Priority claimed from US08/239,090 external-priority patent/US5484585A/en
Priority claimed from US08/247,424 external-priority patent/US5360604A/en
Priority claimed from US08/247,438 external-priority patent/US5531979A/en
Priority claimed from US08/249,424 external-priority patent/US5472682A/en
Application filed by Nycomed Imaging As filed Critical Nycomed Imaging As
Publication of NO964451D0 publication Critical patent/NO964451D0/no
Publication of NO964451L publication Critical patent/NO964451L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/04X-ray contrast preparations
    • A61K49/0433X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/04X-ray contrast preparations
    • A61K49/0433X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • A61K49/0447Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is a halogenated organic compound
    • A61K49/0461Dispersions, colloids, emulsions or suspensions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/04X-ray contrast preparations
    • A61K49/0433X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • A61K49/0447Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is a halogenated organic compound
    • A61K49/0495Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is a halogenated organic compound intended for oral administration
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B82NANOTECHNOLOGY
    • B82YSPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Nanotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Det er beskrevet røntgenkontrastmidler for oral eller retrograd undersøkelse av tarmkanalen, og hvor nevnte middel inneholder et røntgenkontrastmiddel i kombinasjon med en farmasøytisk akseptabel leire i et farmasøytisk akseptabelt bærestoff, foruten fremgangsmåter for deres anvendelse i diagnostisk radiologi av tarmkanalen.
NO964451A 1994-04-21 1996-10-18 Röntgenkontrastblandinger inneholdende farmasöytisk akseptable leirer NO964451L (no)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
US08/230,580 US5476646A (en) 1992-05-01 1994-04-21 X-ray contrast compositions containing iodophenoxyalkanes and pharmaceutically acceptable clays
US08/236,287 US5424056A (en) 1993-03-01 1994-04-29 X-ray contrast compositions containing iodoaniline derivatives and pharmaceutically acceptable clays
US08/237,502 US5492687A (en) 1993-03-11 1994-05-03 Compositions of iodophenoxy alkylene ethers and pharmaceutically acceptable clays for visualization of the gastrointestinal tract
US08/239,090 US5484585A (en) 1993-03-11 1994-05-05 Compositions of iodobenzoic acid derivatives and pharmaceutically acceptable clays for visualization of the gastrointestinal tract
US08/247,424 US5360604A (en) 1994-04-14 1994-05-23 X-ray contrast compositions containing an organic crystalline X-ray contrast agent in combination with pharmaceutically acceptable clays
US08/247,438 US5531979A (en) 1993-02-02 1994-05-23 Compositions of iodophenoxy alkanes and iodophenyl ethers and pharmaceutically acceptable clays for visualization of the gastrointestinal tract
US08/249,424 US5472682A (en) 1993-03-31 1994-05-26 Compositions of iodophenyl esters and iodophenyl sulfonates and pharmaceutically acceptable clays for visualization of the gastrointestinal tract
PCT/GB1995/000566 WO1995028969A1 (en) 1994-04-21 1995-03-16 X-ray contrast compositions containing pharmaceutically acceptable clays

Publications (2)

Publication Number Publication Date
NO964451D0 NO964451D0 (no) 1996-10-18
NO964451L true NO964451L (no) 1996-12-18

Family

ID=27569393

Family Applications (1)

Application Number Title Priority Date Filing Date
NO964451A NO964451L (no) 1994-04-21 1996-10-18 Röntgenkontrastblandinger inneholdende farmasöytisk akseptable leirer

Country Status (9)

Country Link
EP (1) EP0756497A1 (no)
JP (1) JPH09512029A (no)
CN (1) CN1147206A (no)
AU (1) AU1897795A (no)
CA (1) CA2187019A1 (no)
FI (1) FI964212A7 (no)
HU (1) HUT76304A (no)
NO (1) NO964451L (no)
WO (1) WO1995028969A1 (no)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5466440A (en) * 1994-12-30 1995-11-14 Eastman Kodak Company Formulations of oral gastrointestinal diagnostic X-ray contrast agents in combination with pharmaceutically acceptable clays
JP4670229B2 (ja) * 2003-06-10 2011-04-13 味の素株式会社 Ctコロノグラフィにおける消化管造影用組成物
KR100783255B1 (ko) 2004-02-13 2007-12-06 워너-램버트 캄파니 엘엘씨 안드로젠 수용체 조절제
JP2007532621A (ja) 2004-04-13 2007-11-15 ワーナー−ランバート カンパニー リミテッド ライアビリティー カンパニー アンドロゲンモジュレータ
WO2005102990A1 (en) 2004-04-22 2005-11-03 Warner-Lambert Company Llc Androgen modulators
EP1781598A1 (en) 2004-07-08 2007-05-09 Warner-Lambert Company LLC Androgen modulators
CN1330380C (zh) * 2005-03-18 2007-08-08 山东师范大学 一种x-射线造影剂组合物
TW200724139A (en) 2005-05-05 2007-07-01 Warner Lambert Co Androgen modulators
EP2968619B1 (en) 2013-03-15 2021-08-11 The Regents of the University of California Enteric ct contrast material based on low-z atoms
JP2016528259A (ja) 2013-08-16 2016-09-15 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア シリコーン系腸管ct造影材料
CN106075476B (zh) * 2016-07-30 2019-05-31 温州市人民医院 一种造影剂
IL285701B2 (en) * 2019-02-28 2025-07-01 Speed Care Mineral Gmbh Paste for marking textile fabrics and/or other products incapable of x-ray contrast

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB767788A (en) * 1953-12-28 1957-02-06 Schering Corp Polyiodinated phenyl fatty acid compounds and process for their manufacture
CH338274A (fr) * 1954-01-08 1959-05-15 Schering Corp Utilisation comme agents radio-opaques de phénoxy-acides gras polyiodés
CA985626A (en) * 1970-03-10 1976-03-16 E.R. Squibb And Sons Coating composition for moist surface
US5260049A (en) * 1992-05-01 1993-11-09 Sterling Winthrop Inc. X-ray contrast compositions comprising alkoxyphenols
CA2094893A1 (en) * 1992-05-01 1993-11-02 Carl R. Illig X-ray contrast compositions containing film-forming materials
NZ250063A (en) * 1992-12-14 1996-03-26 Eastman Kodak Co Iodinated aromatic acid ester derivatives; x-ray contrast compositions
US5322679A (en) * 1992-12-16 1994-06-21 Sterling Winthrop Inc. Iodinated aroyloxy esters
US5326553A (en) * 1993-02-02 1994-07-05 Sterling Winthrop Inc. Compositions of iodophenoxy alkanes and iodophenyl ethers in film-forming materials for visualization of the gastrointestinal tract
US5316755A (en) * 1993-02-02 1994-05-31 Sterling Winthrop Inc. Compositions of iodophenoxy alkanes and iodophenyl ethers for visualization of the gastrointestinal tract
US5308607A (en) * 1993-02-04 1994-05-03 Sterling Winthrop Inc. Compositions of alkylbenzenes for visualization of the gastrointestinal tract using X-ray contrast
US5334370A (en) * 1993-02-04 1994-08-02 Sterling Winthrop Inc. Compositions of alkylbenzenes in film-forming materials for visualization of the gastrointestinal tract
US5310537A (en) * 1993-03-01 1994-05-10 Sterling Winthrop Inc. Compositions of iodoaniline derivatives for visualization of the gastrointestinal tract
US5310538A (en) * 1993-03-11 1994-05-10 Sterling Winthrop Inc. Compositions of iodophenoxy alkylene ethers in film-forming materials for visualization of the gastrointestinal tract
US5344638A (en) * 1993-03-11 1994-09-06 Sterling Winthrop Inc. Compositions of iodobenzoic acid derivatives for visualization of the gastrointestinal tract
US5312616A (en) * 1993-03-11 1994-05-17 Sterling Winthrop Inc. Compositions of iodobenzoic acid derivatives in film-forming materials for visualization of the gastrointestinal tract
US5336484A (en) * 1993-03-31 1994-08-09 Sterling Winthrop Inc. Compositions of iodophenyl esters and iodophenyl sulfonates in film-forming materials for visualization of the gastronintestinal tract
US5318769A (en) * 1993-03-31 1994-06-07 Sterling Winthrop Inc. Compositions of iodophenyl esters for X-ray visualization of the gastrointestinal tract
US5360604A (en) * 1994-04-14 1994-11-01 Sterling Winthrop Inc. X-ray contrast compositions containing an organic crystalline X-ray contrast agent in combination with pharmaceutically acceptable clays

Also Published As

Publication number Publication date
AU1897795A (en) 1995-11-16
FI964212A0 (fi) 1996-10-18
EP0756497A1 (en) 1997-02-05
JPH09512029A (ja) 1997-12-02
HUT76304A (en) 1997-07-28
NO964451D0 (no) 1996-10-18
FI964212L (fi) 1996-10-18
WO1995028969A1 (en) 1995-11-02
CN1147206A (zh) 1997-04-09
MX9604899A (es) 1998-03-31
HU9602908D0 (en) 1996-12-30
CA2187019A1 (en) 1995-11-02
FI964212A7 (fi) 1996-10-18

Similar Documents

Publication Publication Date Title
EE9900441A (et) Farmatseutiline kompositsioon N-piperidino-3-pürasoolkarboksamiidi derivaadi, tema soolade ja nende solvaatide suu kaudu manustamiseks
NO964451L (no) Röntgenkontrastblandinger inneholdende farmasöytisk akseptable leirer
AU8296987A (en) Pharmaceutical composition comprising fluticasone propionate
DE69908302D1 (de) Pflegeplatzdiagnostikvorrichtungen
GB9524934D0 (en) Treatment and diagnosis of infections due to helicobacter pylori
DK0799239T3 (da) Diastereomert rene 3-oxo- og 3-thioxo-4-aza-androstan-derivater og anvendelse deraf som antiandrogener
NO973459L (no) Vismut-forbindelser
NO163435C (no) Pasientstol for roentgenundersoekelser.
DE69512924D1 (de) Röntgenstrahlenempfindliche photoleitfähige zusammensetzungen für röntgenradiographie
EE9900450A (et) Tetrahüdropüridoühendid, neid sisaldav ravim ja nende kasutamine
MX9302501A (es) Composiciones radiograficas de contraste, y metodos para su uso en la visualizacion del conducto intestinal
NO965301D0 (no) 2,4,6-trijod-5-substituerte-amino-isoftalatestere nyttige som röntgenkontrastmidler for medisinsk diagnostisk billeddannelse
ES2024695B3 (es) Proceso y dispositivo para la esterilizacion de los conductos de nebulizacion y/o alimentacion de aire de los instrumentos medicos, en especial instrumentos de cirujia dental.
NO963540L (no) Röntgenkontrastblandinger som inneholder cellulosederivater
BR0014687A (pt) Compostos de taxano pentacìclico
IL89335A (en) 6-oxo-pyridazine derivatives, a process for their preparation and pharmaceutical compositions containing these compounds
DE60206599D1 (de) Biotin-derivate und ihre konjugaten mit chelatierungsmitteln
NO962248D0 (no) Joderte bifenylderivater og deres diagnostiske anvendelse
NO903291L (no) Renin-hemmende aminooligohydroksyderivater.
DE69916356D1 (de) Schwenkbarer Patiententisch, insbesondere für Röntgenuntersuchungen
ES2145541T3 (es) Nuevos seco-d-esteroides activos sobre el sistema cardiovascular, procedimientos para su preparacion y composiciones farmaceuticas que los contienen.
IL67400A (en) Octahydro-3,7a-diazacyclohepta(j,k)fluorene derivatives,their preparation and pharmaceutical compositions containing them
IT1270088B (it) Derivati aromatici iodurati e loro impiego diagnostico
FI892577A0 (fi) Vattenhaltig framkallarkomposition foer med loesningsmedel framkallbara fotoresistbelaeggningar.
ES2179029T3 (es) Derivados de 14,15-alfa-metileno-equilenina, proceso para su preparacion y medicamentos que contienen los mismos.